Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
October 14, 2025
Cluster’s breakfast (Śniadanie Klastra) is a regular networking event organized by the Kraków Life Science Cluster1. These meetings bring together professionals, entrepreneurs, researchers, and cluster members from the life sciences and healthcare sectors to foster exchange of ideas, build relationships, and discuss collaborative opportunities. Typically held in an informal breakfast setting, the events combine knowledge sharing, such as short presentations, updates on ongoing projects, and industry trends, with open discussions and community building. Cluster breakfasts play a crucial role in supporting innovation, fostering connections among stakeholders, and advancing the local life sciences ecosystem.
At the most recent Cluster Breakfast, Hemolens Diagnostics® presented a solution that has the potential to support healthcare not only in Europe but worldwide.
The presentation held on September 24th began with a strong focus on the overarching mission to make heart disease diagnosis faster, simpler, and more accessible, regardless of systemic workforce shortages, which are increasingly recognized as a global challenge due to the growing patient demand and limited number of trained specialists. This vision is rooted in supporting healthcare providers and addressing the global gap between cardiac care demand and specialist availability. This perspective was shared by the presenter, Paweł Paluch, Commercial Director at Hemolens Diagnostics®.
“A story that deeply resonated with me involved meeting an elderly British gentleman on a train to Birmingham during a series of UK healthcare meetings – a man whose journey through cardiac diagnostics was marked by long waits for scans, results, and specialist consultations. His months of uncertainty, anxiety, and waiting illustrated that healthcare workforce shortages are not just statistics; they are real challenges faced by actual people, who could receive help much sooner if physicians had access to more efficient diagnostic tools,” the presenter said.
As we mentioned, the presenter highlighted the profound workforce crisis in global medicine, underscored by projections of a two-million shortfall in medical specialists by 2030, including cardiologists. This shortage results in diagnostic delays, longer patient waiting times, and an increased risk of adverse outcomes.
Webinar presented significant professional challenges within cardiac diagnostics, emphasizing how workflow fragmentation and communication barriers complicate daily practice for radiologists, general cardiologists, and interventional cardiologists. Radiologists encounter time-intensive image interpretation and a need for clear, actionable reporting. General cardiologists struggle with uncertainty in clinical decisions and require effective tools for visualizing and communicating diagnostic insights. Interventional cardiologists demand precise pre-procedural information, certainty regarding the necessity of invasive interventions, and mechanisms to optimize procedural planning and resource use. These collective challenges underscore the urgent need for streamlined processes and better integration across all specialist roles.
A core innovation presented was the Cardiolens® Platform: a cloud-based, scalable suite of medical-grade tools that could support the physician throughout the full patient’s pathway from imaging to treatment planning and follow-up. Cardiolens® is designed to unify the workflows of the aforementioned medical specialists, facilitating clear communication and smart, data-driven decision support at many stages of diagnostics.
Key modules include:
Hemolens Diagnostics distinguishes itself through the integration of three advanced domains: artificial intelligence (speed and automation in image interpretation), bioengineering (patient-specific modeling beyond generic statistical approaches), and computational fluid dynamics (with non-invasive blood flow and pressure simulation). This unique triple-engine approach has been protected by patents, making the Cardiolens Platform not just “the next software” but a stepwise leap toward personalized, accurate cardiac diagnostics.
“In an era of increasing numbers of patients with cardiovascular diseases, the development of personalized diagnostic tools presents both an opportunity and a challenge. Per-patient solutions offer the possibility of earlier and more accurate diagnosis. Still, they also pose the challenge of developing a tool that is not only effective but also time- and cost-efficient. The use of solutions based on CFD numerical analysis and artificial intelligence offers hope for meeting these challenges. However, in order to ensure the safety and effectiveness of the method, independent testing, both clinical and in simulated systems, is a key aspect. In a broader context, I see the prospect of greater use of in silico methods in medicine, as well as other modern methods of personalizing medicine, such as 3D printing and its use in treatment planning, “ – said webinar participant Krystian Jędrzejczak, PhD, research assistant professor at the Warsaw University of Technology.
Pilot deployments of Cardiolens, currently available as a research-use-only cloud solution, have received positive feedback—particularly for its intuitive visualization and accuracy in identifying clinically significant lesions. Real-world collaborations with clinical centers are underway to further test the technology, assess its experimental MVP, and support broader scalability. Notably, the platform’s remote, asynchronous workflow design enables faster diagnosis and reduces the time commitment required from specialists.
If you haven’t subscribed to our newsletter yet, you can do so here.
Panel Q&A addressed practical barriers – mainly regulatory – in adopting such technology across diverse healthcare systems. Hemolens is pursuing medical device certification (targeted for 2026) and expanding pilot partnerships both in Poland and internationally, including the UK, the Netherlands, and soon, the United States. The open ecosystem approach welcomes collaboration with clinicians and institutes to ensure relevance and long-term adoption.
Concluding the session, the Hemolens team outlined its vision: to support cardiologists, radiologists, and healthcare decision-makers in their key pain points with potentially efficient, accurate, and non-invasive cardiac diagnostics, regardless of regional resource constraints. Through AI-focused innovation grounded in multidisciplinary expertise, Hemolens Diagnostics positions itself as a key partner in helping healthcare systems bridge capacity shortages and drive the global shift toward preventive, personalized, and scalable cardiac care.
